Evidence map›Paper›PMID 19279216›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

Neurodegeneration mutations in dynactin impair dynein-dependent nuclear migration.

Jeffrey K Moore, David Sept, John A Cooper

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Multiple roles for the cytoskeleton in ALS.Experimental neurology · 2022
    Review
  4. A novel variant inCold Spring Harbor molecular case studies · 2022
    Review
  5. Article
  6. Article
  7. On and off controls within dynein-dynactin on native cargoes.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Nuclear movement in fungi.Seminars in cell & developmental biology · 2018
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jeffrey K MooreDepartment of Cell Biology and Physiology, Washington University, Saint Louis, MO 63110, USA.
David Sept
John A Cooper
Washington University in St. Louis · US

Funding

MOLECULAR ONCOLOGY TRAINING GRANTT32CA113275 · NCI · WASHINGTON UNIVERSITY · PI Matthew J Walter · 2006 to 2026
$5.7M
The Function of Dynein in Budding YeastR01GM047337 · NIGMS · WASHINGTON UNIVERSITY · PI COOPER, JOHN A · 1993 to 2009
$2.6M
Protein interactions underlying actin-based motilityR01GM067246 · NIGMS · WASHINGTON UNIVERSITY · PI SEPT, DAVID S. · 2002 to 2006
$1.3M
NCI NIH HHS T-32-CA113275NCI NIH HHS T32 CA113275NIGMS NIH HHS GM47337NIGMS NIH HHS GM67246NIGMS NIH HHS R01 GM047337NIGMS NIH HHS R01 GM067246
6 · The paper itself

Abstract

Neurodegenerative disease in humans and mice can be caused by mutations affecting the microtubule motor dynein or its biochemical regulator, dynactin, a multiprotein complex required for dynein function (1-4). A single amino acid change, G59S, in the conserved cytoskeletal-associated protein glycine-rich (CAP-Gly) domain of the p150(glued) subunit of dynactin can cause motor neuron degeneration in humans and mice, which resembles ALS (2, 5-8). The molecular mechanism by which G59S impairs the function of dynein is not understood. Also, the relevance of the CAP-Gly domain for dynein motility has not been demonstrated in vivo. Here, we generate a mutant that is analogous to G59S in budding yeast, and show that this mutation produces a highly specific phenotype related to dynein function. The effect of the point mutation is identical to that of complete loss of the CAP-Gly domain. Our results demonstrate that the CAP-Gly domain has a critical role in the initiation and persistence of dynein-dependent movement of the mitotic spindle and nucleus, but it is otherwise dispensable for dynein-based movement. The need for this function appears to be context-dependent, and we speculate that CAP-Gly activity may only be necessary when dynein needs to overcome high force thresholds to produce movement.

Indexed as

Mutation, MissenseCell NucleusDynactin ComplexDyneinsHumansMicrotubule-Associated ProteinsMovementNerve DegenerationProtein SubunitsSpindle ApparatusYeastsDCTN1 protein, humanDctn1 protein, mouseDynactin ComplexDyneinsMicrotubule-Associated ProteinsProtein Subunits

Identifiers

PMID19279216
PMCPMC2664072
OpenAlexW2138882854

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.